IP Verse

Il-15 Heterogeneous Dimer Protein And Uses Thereof

PatentPatent Analysis

EP3093295

JIANGSU HENGRUI MEDICINE
Application Number
EP14878154A
Filing Date
Dec 25, 2014
Status
Revoked
Jun 2, 2023
Grant Date
May 27, 2020
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3093295B1 was granted to Jiangsu Hengrui Medicine on May 27, 2020 following the initial filing on Dec 25, 2014 under the application number EP14878154A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MARGARET DIXONMar 1, 2021ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents